Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva
M
M
Transplantation Microsurgery Laboratory, Queen Elizabeth Hospital, University of Birmingham, Edgbaston, United Kingdom.
Antoniou
E
E
DeRoover
A
A
Nishimura
Y
Y
Howie
A
A
McMaster
P
P
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006650:Histocompatibility Testing; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013154:Spleen / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous / Q000473:pathology; D011798:Quinaldines
D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide; D016559:Tacrolimus; C046943:brequinar; D011798:Quinaldines